feed,title,long_url,short_url
SeekingAlpha,NRx Pharma begins phase II trial to test bipolar depression drug candidate,https://seekingalpha.com/news/3837762,
SeekingAlpha,"Dillard's GAAP EPS of $13.68 beats by $7.24, revenue of $1.64B beats by $90M",https://seekingalpha.com/news/3837761,
SeekingAlpha,Swiss biotech MoonLake begins dosing in mid-stage study of sonelokimab for skin disorder,https://seekingalpha.com/news/3837759,
SeekingAlpha,"Aemetis GAAP EPS of -$0.54 misses by $0.13, revenue of $52.05M misses by $3.24M",https://seekingalpha.com/news/3837760,
SeekingAlpha,Megacap names have worst start to the year since 2008 and these ETNs are feeling it,https://seekingalpha.com/news/3837732,
SeekingAlpha,International Tower Hill GAAP EPS of C$0.00,https://seekingalpha.com/news/3837758,
SeekingAlpha,"AITX's subsidiary Robotic Assistance Devices receives new orders, signs new dealer",https://seekingalpha.com/news/3837757,
